Inj, nafcillin sodium, 20 mg
Products billed under this code include Nafcillin Sodium, Naficillin Sodium.
Payment limit per 20 MG, by effective quarter, 3Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J2290
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Nafcillin Sodium | Heritage Pharmaceuticals Inc. | 23155-0906-41 | 500 | $23.50 |
| Nafcillin Sodium | Heritage Pharmaceuticals Inc. | 23155-0907-41 | 1000 | $47.00 |
| Nafcillin Sodium | Sagent Pharmaceuticals | 25021-0139-10 | 500 | $23.50 |
| Nafcillin Sodium | Sagent Pharmaceuticals | 25021-0140-10 | 1000 | $47.00 |
| Nafcillin Sodium | Sagent Pharmaceuticals | 25021-0141-99 | 5000 | $235.00 |
| Nafcillin Sodium | Sagent Pharmaceuticals | 25021-0198-99 | 500 | $23.50 |
| Nafcillin Sodium | WG Critical Care, LLC | 44567-0221-10 | 500 | $23.50 |
| Nafcillin Sodium | WG Critical Care, LLC | 44567-0222-10 | 1000 | $47.00 |
| Nafcillin Sodium | WG Critical Care, LLC | 44567-0223-01 | 500 | $23.50 |
| Nafcillin Sodium | Eugia US LLC | 55150-0122-15 | 500 | $23.50 |
Show all 25 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Nafcillin Sodium | Eugia US LLC | 55150-0123-15 | 1000 | $47.00 |
| Nafcillin Sodium | Eugia US LLC | 55150-0123-16 | 1000 | $47.00 |
| Nafcillin Sodium | Eugia US LLC | 55150-0124-09 | 500 | $23.50 |
| Nafcillin Sodium | Eugia US LLC | 55150-0124-99 | 500 | $23.50 |
| Nafcillin Sodium | FreseniUS Kabi USA, LLC | 63323-0327-10 | 500 | $23.50 |
| Nafcillin Sodium | FreseniUS Kabi USA, LLC | 63323-0328-20 | 1000 | $47.00 |
| Nafcillin Sodium | FreseniUS Kabi USA, LLC | 63323-0328-22 | 1000 | $47.00 |
| Nafcillin Sodium | FreseniUS Kabi USA, LLC | 63323-0330-60 | 500 | $23.50 |
| Nafcillin Sodium | Athenex Pharmaceutical Division, LLC | 70860-0116-26 | 500 | $23.50 |
| Nafcillin Sodium | Athenex Pharmaceutical Division, LLC | 70860-0117-26 | 1000 | $47.00 |
| Nafcillin Sodium | Athenex Pharmaceutical Division, LLC | 70860-0119-99 | 500 | $23.50 |
| Nafcillin Sodium | Armas Pharmaceuticals Inc. | 72485-0406-10 | 1000 | $47.00 |
| Nafcillin Sodium | Northstar RxLLC | 72603-0453-10 | 1000 | $47.00 |
| Nafcillin Sodium | Northstar RxLLC | 72603-0567-01 | 500 | $23.50 |
| Naficillin Sodium | Avenacy Inc. | 83634-0101-99 | 500 | $23.50 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.047 | $0.00 | 20 MG | Inj, nafcillin sodium, 20 mg | v1, posted September 17, 2026 |
| 3Q26 | $0.047 | −$0.001 | 20 MG | Inj, nafcillin sodium, 20 mg | v1, posted September 15, 2026 |
| 2Q26 | $0.048 | −$0.014 | 20 MG | Inj, nafcillin sodium, 20 mg | v1, posted September 15, 2026 |
| 1Q26 | $0.062 | +$0.008 | 20 MG | Inj, nafcillin sodium, 20 mg | v1, posted September 15, 2026 |
| 4Q25 | $0.054 | −$0.003 | 20 MG | Inj, nafcillin sodium, 20 mg | v1, posted September 8, 2026 |
| 3Q25 | $0.057 | – | 20 MG | Inj, nafcillin sodium, 20 mg | v1, posted March 10, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026